buparvaquone has been researched along with imidocarb dipropionate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dwivedi, SK; Gupta, AK; Kumar, S; Pal, Y | 1 |
| Bartolomé, A; Checa, R; Gálvez, R; González-Fraga, JL; Marino, V; Miró, G; Montoya, A; Ortega, N | 1 |
1 trial(s) available for buparvaquone and imidocarb dipropionate
| Article | Year |
|---|---|
In-vivo therapeutic efficacy trial with artemisinin derivative, buparvaquone and imidocarb dipropionate against Babesia equi infection in donkeys.
Topics: Animals; Antiprotozoal Agents; Artemisinins; Babesiosis; Blood Cell Count; Drug Therapy, Combination; Equidae; Imidocarb; India; Naphthoquinones; Sesquiterpenes; Splenectomy | 2003 |
1 other study(ies) available for buparvaquone and imidocarb dipropionate
| Article | Year |
|---|---|
Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm.
Topics: Animals; Antiprotozoal Agents; Atovaquone; Azithromycin; Babesia microti; Babesiosis; Dog Diseases; Dogs; Drug Therapy, Combination; Europe; Female; Imidocarb; Male; Naphthoquinones; Parasitemia; Polymerase Chain Reaction | 2017 |